Sanggenon D is primarily studied for its significant biological activities, particularly in the field of pharmacology. It exhibits strong anti-inflammatory effects by inhibiting key signaling pathways such as NF-κB, making it a potential candidate for treating inflammatory diseases. It also demonstrates neuroprotective properties, showing promise in research related to neurodegenerative conditions like Alzheimer’s disease due to its ability to reduce oxidative stress and prevent neuronal cell damage.

In addition, Sanggenon D has been investigated for its anticancer potential. It induces apoptosis and suppresses proliferation in various cancer cell lines, including liver and breast cancer cells, through modulation of apoptotic proteins and cell cycle arrest. Its antioxidant activity further supports its role in cellular protection against free radical damage.

Due to these properties, Sanggenon D is considered a lead compound in the development of natural product-based therapeutics, especially in traditional medicine-derived drug discovery.